Comparison of cystatin C-based and creatinine-based glomerular filtration rate in the prediction of postoperative residual hypertension in aldosterone-producing adenoma patients after adrenalectomy.

Clinica Chimica Acta; International Journal of Clinical Chemistry
Ching-Way ChenYen-Hung Lin

Abstract

Renal function is associated with postoperative residual hypertension in aldosterone-producing adenoma(APA) patients. Cystatin C-based glomerular filtration rate (GFR) can more accurately estimate renal function than creatinine-based methods. However, which renal function estimation method can more accurately predict postoperative hypertension in APA patients is still unknown. We recruited 180 APA patients who underwent adrenalectomy. Preoperative creatinine and cystatin C-based GFRs were calculated. Residual hypertension was defined as persistent hypertension > 140/90 mmHg or requiring anti-hypertensive medications 1 year after surgery. Sixty-five(36.1%) of the 180 APA patients had residual hypertension. Multivariate logistic regression and receiver operating characteristic (ROC) curve analysis showed a combination of creatinine and cystatin method CKD-EPI (Chronic Kidney Disease Epidemiology Collaboration) creatinine-cystatin GFR was significantly associated with residual postoperative hypertension and had the largest area under the ROC curve, which was statistically larger than that of Cockcroft-Gault creatinine-based GFR. In both net reclassification index and integrated discrimination index models, CKD-EPI creatinine-cysta...Continue Reading

References

Jan 1, 1976·Nephron·D W Cockcroft, M H Gault
Apr 28, 2001·American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation·Y HoritaS Takishita
Aug 21, 2001·Annals of Internal Medicine·A M SawkaJ A van Heerden
Sep 19, 2003·Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association·Frans J HoekRaymond T Krediet
Jun 9, 2006·The New England Journal of Medicine·Lesley A StevensAndrew S Levey
Aug 16, 2006·Annals of Internal Medicine·Andrew S LeveyUNKNOWN Chronic Kidney Disease Epidemiology Collaboration
Sep 22, 2006·Journal of the American Society of Nephrology : JASN·Ying-Chun MaHai-Yan Wang
May 31, 2007·Diabetes Care·Marie-Christine BeauvieuxVincent Rigalleau
Feb 26, 2008·American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation·Lesley A StevensAndrew S Levey
Feb 17, 2009·Arquivos brasileiros de cardiologia·Maria Jacqueline Silva RibeiroThiara Castro de Oliveira
Jul 25, 2009·American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation·UNKNOWN TAIPAI Study GroupKwan-Dun Wu
Sep 18, 2009·Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine·Ruoh-Fang YenUNKNOWN TAIPAI Study Group
Oct 17, 2009·Journal of the American Society of Nephrology : JASN·Lesley A Stevens, Andrew S Levey
May 21, 2010·Orphanet Journal of Rare Diseases·Laurence AmarOlivier Steichen
Jun 19, 2010·American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation·Lesley A StevensAndrew S Levey
Jul 29, 2010·Current Hypertension Reports·Gian Paolo Rossi
Aug 19, 2010·Clinical Chemistry and Laboratory Medicine : CCLM·Michael J PencinaRamachandran S Vasan
Sep 17, 2010·Kidney International·Bjørn O EriksenIngrid Toft
Feb 25, 2011·Clinica Chimica Acta; International Journal of Clinical Chemistry·Vin-Cent WuUNKNOWN TAIPAI Study Group
Mar 12, 2011·Journal of the Renin-angiotensin-aldosterone System : JRAAS·Chin-Chi Kuo Taipai Study Group
Aug 23, 2011·American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation·Lesley A InkerJosef Coresh
Jun 13, 2012·Journal of Hypertension·Yen-Hung LinUNKNOWN TAIPAI Study Group
Jul 6, 2012·The New England Journal of Medicine·Lesley A InkerUNKNOWN CKD-EPI Investigators
Aug 10, 2012·American Journal of Epidemiology·Michael J PencinaPhilip Greenland
Oct 30, 2012·International Surgery·Wei WangHai Huang
May 25, 2013·Annals of Medicine·Chia-Ter ChaoMichael Stowasser
Jan 1, 2013·Kidney International Supplements
Sep 13, 2014·Diabetes & Metabolism Journal·Kwang-Sook WooJin-Yeong Han
Feb 20, 2016·Anesthesia and Analgesia·Elizabeth S JewellMichael Elliott
Sep 3, 2016·Scientific Reports·Vin-Cent WuKwan-Dun Wu
Jun 4, 2017·The Lancet. Diabetes & Endocrinology·Tracy A WilliamsUNKNOWN Primary Aldosteronism Surgery Outcome (PASO) investigators
Jul 25, 2017·Journal of the Formosan Medical Association = Taiwan Yi Zhi·Vin-Cent WuUNKNOWN TAIPAI group
Nov 18, 2017·Hormone and Metabolic Research = Hormon- Und Stoffwechselforschung = Hormones Et Métabolisme·Fabrizio BuffoloPaolo Mulatero
May 19, 2018·Journal of Clinical Pharmacology·Sumit KarRafiqul Islam
Jun 28, 2018·International Urology and Nephrology·Changjie GuanJunzhou Fu

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antihypertensive Agents: Mechanisms of Action

Antihypertensive drugs are used to treat hypertension (high blood pressure) which aims to prevent the complications of high blood pressure, such as stroke and myocardial infarction. Discover the latest research on antihypertensive drugs and their mechanism of action here.

Related Papers

Strahlentherapie und Onkologie : Organ der Deutschen Röntgengesellschaft ... [et al]
Edwin BölkeWilfried Budach
Deutsches Ärzteblatt International
Christian Thomas, Lothar Thomas
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
Benjamin L LaskinSonata Jodele
Annals of Thoracic and Cardiovascular Surgery : Official Journal of the Association of Thoracic and Cardiovascular Surgeons of Asia
Kati JarvelaTero Sisto
© 2021 Meta ULC. All rights reserved